Atlas Trials

Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC

Clinical trial NCT06456515 · RECRUITING

Trial details

NCT number
NCT06456515
Sponsor
The First People's Hospital of Changzhou
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2024-05-01
Primary completion
2026-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.